News, Analysis & Insights on Nutrition, Supplements, and Health
Disappointing figures from flavours company Quest pulled an already less than dazzling set of third quarter results down further for UK chemical group ICI hit by a continuing malaise in US and European sales. National Starch figures crept up but...
The American Association of Clinical Endocrinologists has released medical guidelines on the clinical use of dietary supplements and nutraceuticals, to better educate doctors about the risks and benefits of natural products, it claims.
The rolling out of third quarter results today continues with a slip in earnings for US agri-giant Bunge on the back of weaker profits sorely felt in the agribusiness division.
Perillyl alcohol (PEOH), found naturally in mint and citrus fruits and also used as a food additive, is a powerful inhibitor of both UVB-induced non-melanoma and melanoma, reported researchers this week.
Pricing pressure hits another ingredients company as leading Australian yeast supplier Burns Philp sees low margins cutting into profit for the quarter.
Experts attending this week's meeting on cancer prevention heard a number of studies to back green tea's powerful anti-cancer effects in humans. The tea's active agent, Epigallocatecin-3-gallate, is already thought to lower cholesterol, prevent heart...
Functional drinks from innovative UK firm Extreme Drinks are to be rolled out in leading French supermarkets, after initial success in the Alps region last year. Targeting extreme sport fans, the range enters one of the least competitive energy drink...
An Australian government review of herbal and complementary medicines looks set to provoke a wave of extensive reforms to the sector, giving the national medicines body greater powers to regulate natural health products.
The American government is funding new research into complementary medicine, in the hope that ancient knowledge from other cultures may one day also benefit the US public.
Utah supplement maker Nature's Sunshine Products saw sales slip in the nine months to end of September, with poor revenue in the US offsetting better performance in international markets.
Experts attending this week's meeting on cancer prevention heard a number of studies to back green tea's powerful anti-cancer effects in humans. The tea's active agent, Epigallocatecin-3-gallate, is already thought to lower cholesterol, prevent heart...